FIELD: biotechnology.
SUBSTANCE: invention can be used in medical practice. The invention discloses a vaccine adjuvant based on zinc zoledronate microparticles, which contains zinc and zoledronic acid, respectively, as well as possible additives based on phosphate and aluminum. The method of its preparation includes carrying out mixed precipitation in a soluble salt solution containing zinc ions, zoledronic acid and sodium hydroxide.
EFFECT: invention can be used as an immunostimulating additive and adjuvant in the preparation of pharmaceutical compositions and formulations.
19 cl, 9 ex, 6 tbl, 7 dwg
Title | Year | Author | Number |
---|---|---|---|
OBTAINING A MICRO/NANOADJUVANT BASED ON RIZEDRONATE ZINC AND ITS USE AS A VACCINE ADJUVANT | 2020 |
|
RU2797509C1 |
ADJUVANT | 2020 |
|
RU2736933C1 |
ADJUVANT BASED ON POLYINOSINIC ACID-POLYCYTIDYLIC ACID | 2005 |
|
RU2383552C2 |
OIL-BASED ADJUVANTS | 2014 |
|
RU2730011C2 |
OIL-BASED ADJUVANTS | 2014 |
|
RU2816849C2 |
NEW VACCINE FORMULATIONS CONTAINING SAPONIN-CONTAINING ADJUVANTS | 2010 |
|
RU2555342C2 |
COMPOSITION OF VACCINES WITH DOUBLE ADJUVANT, PREPARATION AND USE | 2015 |
|
RU2729646C2 |
ADJUVANT COMPOSITION CONTAINING POLY-GAMMA-GLUTAMIC ACID | 2005 |
|
RU2390352C2 |
OIL-BASED ADJUVANTS | 2014 |
|
RU2816851C2 |
METHOD OF PRODUCING VACCINE ADJUVANT IN FORM OF EMULSION | 2022 |
|
RU2811696C1 |
Authors
Dates
2023-08-11—Published
2020-04-10—Filed